Articles & posts – MFN

This page contains articles and posts from 2025.

Neola Medical's product for lung monitoring of preterm born infants, Neola®, is one of ten innovations selected to be presented to a panel of judges at...
CEO Hanna Sjöström comments on Neola Medical's Q4 report of 2023 in BioStock's studio. Following the interview, Jonas Söderström, CEO of BioStock...
Apart from presenting the company’s financial position and the important highlights from this quarter, they also talk more about the significance of...
Press communication Lund, Sweden, February 14 This is a translation of the Swedish press release published 2024-02-14, 08.00 CET Neola Medical AB (publ)...
Today, on February 8, it's time for MedInnovation 2024 at Medicon Village in Lund. Neola Medical's CEO Hanna Sjöström will be present and present as...
On February 6th, it was time for this year's Medtech Matchday 2024 at GoCo Health Innovation City in Gothenburg. Neola Medical's CEO, Hanna Sjöström...
Press communication Lund, Sweden, 5 February 2024 This is a translation of the Swedish press release published 2024-02-05 Neola Medical AB (publ) invites...
Today, on January 30th, the annual SwedenBIO Summit 2024 will take place in Stockholm. Neola Medical's CEO Hanna Sjöström will be present and interviewed...
The 42nd edition of the JPMorgan Health Conference took place last week, and one of the participants was Neola Medical. The Swedish medtech is currently...
Neola Medical is one of seven companies selected to participate in the new 10XHealth scale-up program developed by SmiLe in close collaboration with Medicon...

For Investors

We are on a journey to revolutionize neonatal intensive care
Learn more about investing in Neola Medical